90992-9 |
Monoclonal gammopathy panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Monoclonal gammopathy panel - Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
90992-9 |
|
|
|
|
Order |
|
|
|
0 |
Monoclonal gammopathy Pnl SerPl |
|
|
|
|
|
Chemistry; Monoclonal gammopathy Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.65 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
90993-7 |
Iothalamate clearance panel |
- |
Urine+Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Iothalamate clearance panel - Urine and Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
90993-7 |
|
|
|
|
Order |
|
|
|
0 |
Iothal clear Pnl Ur+SerPl |
|
|
|
|
|
Chemistry; Cl; Clear; Clearanc; Clearances; Clr; GFR; Iothal clear; Iothal clear Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn |
2.65 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
90994-5 |
Iothalamate clearance |
VRat |
Urine+Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Iothalamate renal clearance |
|
ADD |
DefinitionDescription |
|
|
mL/min |
|
|
|
|
|
|
CHEM |
|
90994-5 |
|
|
|
|
Both |
|
|
|
0 |
Iothalamate renal clearance |
|
|
|
|
|
Chemistry; Cl; Clear; Clearanc; Clearances; Clr; Flow; GFR; Iothal clear; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn; Volume rate; vRate |
2.65 |
2.65 |
|
|
|
|
|
|
|
mL/min |
|
|
|
0 |
90995-2 |
Iothalamate clearance/Body surface area |
ArVRat |
Urine+Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Iothalamate renal clearance/Body surface area |
|
ADD |
DefinitionDescription |
|
|
mL/min/m2 |
|
|
|
|
|
|
CHEM |
|
90995-2 |
|
|
|
|
Both |
|
|
|
0 |
Iothalamate renal clearance/BSA |
|
|
|
|
|
Bdy surface; bod; Bodies; BSA; Chemistry; Cl; Clear; Clearanc; Clearances; Clr; GFR; Iothal clear; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Surf; UA; UR; Ur+SerPl; Urn; Volume rate/area; Volume Rate/Ratio |
2.65 |
2.65 |
|
|
|
|
|
|
|
mL/min/m2 |
|
|
|
0 |
90996-0 |
HEDIS 2019-2020 Value Set - Glucose Tests |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2019-2020 Value Set - Glucose Tests |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
90996-0 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2019-20 Glucose Tests |
|
|
|
|
|
Glu; Gluc; Glucoseur; HEDIS 2019-20 Glucose Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.69 |
2.65 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
90997-8 |
HEDIS 2019-2020 Value Set - Group A Strep Tests |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2019-2020 Value Set - Group A Strep Tests |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
90997-8 |
|
|
|
|
Both |
|
|
|
0 |
HEDIS 2019-20 Grp A Strep |
|
|
|
|
|
HEDIS 2019-20 Grp A Strep; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.69 |
2.65 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
90998-6 |
Analysis of information sources |
Find |
^Event |
Pt |
Nar |
|
|
ACTIVE |
Analysis of information sources |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CDC |
|
90998-6 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.CDC |
2.68 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
90999-4 |
Analysis of emergency department visits |
Find |
^Event |
Pt |
Nar |
|
|
ACTIVE |
Analysis of emergency department visits |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CDC |
|
90999-4 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Analysis of ED visits; ED visits; Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.CDC |
2.68 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91-9 |
Cefodizime |
Susc |
Isolate |
Pt |
Qn |
MLC |
|
ACTIVE |
Cefodizime [Susceptibility] by Minimum lethal concentration (MLC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
91-9 |
|
MLC |
|
|
Observation |
|
|
|
0 |
Cefodizime Islt MLC |
|
|
|
Y |
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Timecef |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
910-0 |
Ax Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Ax Ab [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
910-0 |
|
|
|
|
Observation |
|
|
|
0 |
Ax Ab SerPl Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Ao; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
9100-9 |
Class |
Type |
Rate control device |
Pt |
Nom |
|
|
ACTIVE |
Type of Rate control device |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DEVICES |
|
9100-9 |
|
|
|
|
|
|
|
|
0 |
Rate Control Device Class |
|
|
|
|
|
Nominal; Point in time; Random; Typ |
2.27 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
91000-0 |
Cases |
Num |
^Event |
RptPeriod |
Qn |
|
|
ACTIVE |
Event-associated cases [#] during reporting period |
|
MIN |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
PUBLICHEALTH |
|
91000-0 |
|
|
|
|
Observation |
|
|
|
0 |
Event-associated cases # in RptPeriod |
|
|
|
|
|
Cnt; Count; Number; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period |
2.69 |
2.65 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
91001-8 |
Myelin associated glycoprotein Ab.IgM |
Titr |
CSF |
Pt |
SemiQn |
IA |
|
ACTIVE |
Myelin associated glycoprotein IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
91001-8 |
|
IA |
|
|
Both |
|
|
|
0 |
MAG IgM Titr CSF IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; IAA; Immune globulin M; Immunoglobulin M; MAG; MAGM; MEIA; Neuro; Neurology; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Titer; Titered; Titre; Ttr |
2.75 |
2.65 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
91002-6 |
Job position |
Type |
Personnel |
Pt |
Nom |
|
|
ACTIVE |
Personnel Job position |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
91002-6 |
|
|
|
|
Observation |
|
|
|
0 |
Personnel Job position |
|
|
|
|
|
ADMIN; Nominal; Occupation; Point in time; Random; Typ; Work |
2.68 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91003-4 |
Personnel contact information panel |
- |
Personnel |
Pt |
- |
|
|
ACTIVE |
Personnel contact information panel |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.ADMIN |
|
91003-4 |
|
|
|
|
Both |
|
|
|
0 |
Personnel contact info Pnl |
|
|
|
|
|
ADMIN; Pan; PANEL.ADMIN; Panl; Personnel contact info Pnl; Pnl; Point in time; Random |
2.68 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
Updated Component name from "Distribution list panel" to "Personnel contact information panel" to better define the child elements contained within the panel. |
0 |
91004-2 |
Email address |
EmailAddr |
Personnel |
Pt |
Nom |
|
|
DEPRECATED |
Deprecated Email address Personnel |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
91004-2 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated Email address Personnel |
|
|
|
|
|
ADMIN; Nominal; Point in time; Random |
2.66 |
2.65 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
91005-9 |
Organization assigned to task |
ID |
Organization |
Pt |
Nom |
|
|
ACTIVE |
Organization assigned to task |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
91005-9 |
|
|
|
|
Observation |
|
|
|
0 |
Org assigned to task |
|
|
|
|
|
ADMIN; Ident; Identifier; Nominal; Org assigned to task; Point in time; Random |
2.68 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91006-7 |
New cases per D |
NRat |
^Event |
RptPeriod^mean |
Qn |
|
|
ACTIVE |
New cases per day Reporting Period mean |
|
MIN |
DefinitionDescription |
|
|
/d |
|
|
|
|
|
|
PUBLICHEALTH |
|
91006-7 |
|
|
|
|
Observation |
|
|
|
0 |
New cases per D RptPeriod Mean nRate |
|
|
|
|
|
Average; Avg; Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period |
2.68 |
2.65 |
|
|
|
|
|
|
|
/d |
|
|
|
0 |
91007-5 |
Total cases |
Num |
^Event |
Pt |
Qn |
|
|
ACTIVE |
Total event-associated cases [#] |
|
NAM |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
PUBLICHEALTH |
|
91007-5 |
|
|
|
|
Observation |
|
|
|
0 |
Total event-associated cases # |
|
|
|
|
|
Cnt; Count; Number; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Tot; Totl |
2.69 |
2.65 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
91008-3 |
Date and time of deaths assessment |
TmStp |
^Event |
Pt |
Qn |
|
|
ACTIVE |
Date and time of deaths assessment |
|
NAM |
DefinitionDescription |
|
|
TmStp |
|
|
|
|
|
|
PUBLICHEALTH |
|
91008-3 |
|
|
|
|
Observation |
|
|
|
0 |
D/T of deaths assessment |
|
|
|
|
|
D/T of deaths assessment; Date and time; Date+time; Death; Fatalities; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp |
2.69 |
2.65 |
|
|
|
|
|
|
|
{tmstp} |
|
|
|
0 |
91009-1 |
Deaths |
Num |
^Event |
Pt |
Qn |
|
|
ACTIVE |
Total event-associated deaths [#] |
|
NAM |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
PUBLICHEALTH |
|
91009-1 |
|
|
|
|
Observation |
|
|
|
0 |
Total event-associated deaths # |
|
|
|
|
|
Cnt; Count; Fatalities; Number; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random |
2.69 |
2.65 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
9101-7 |
Class |
Type |
Fluid intake substance |
Pt |
Nom |
|
|
ACTIVE |
Type of Fluid intake substance |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
IO_IN.ATOM |
|
9101-7 |
|
|
|
|
|
|
|
|
0 |
Fluid intake substance Class |
|
|
|
|
|
IO_INTAKE; IO_INTAKE.ATOM; Nominal; Point in time; Random; Subs; Typ |
2.27 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
91010-9 |
Epidemiological investigation report |
Find |
^Event |
Pt |
Doc |
|
|
ACTIVE |
Epidemiological investigation report Document |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.PUBLICHEALTH |
|
91010-9 |
|
|
|
|
Both |
|
|
|
0 |
Epidemiological investigation report Doc |
|
|
|
|
|
Document; Finding; Findings; Point in time; Public Health; Public Health Documents; PUBLICHEALTH; Random |
2.68 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91011-7 |
Etiology of a public health emergency |
Type |
^Event |
Pt |
Nom |
|
|
ACTIVE |
Etiology of a public health emergency |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PUBLICHEALTH |
|
91011-7 |
|
|
|
|
Observation |
|
|
|
0 |
Etiology of a PH emergency |
|
|
|
|
|
Etiology of a PH emergency; Nominal; Point in time; Public Health; PUBLICHEALTH; Random; Typ |
2.68 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91012-5 |
Symptoms related to incident or outbreak |
Find |
^Population |
Pt |
Nom |
|
|
ACTIVE |
Population Symptoms related to incident or outbreak |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PUBLICHEALTH |
|
91012-5 |
|
|
|
|
Observation |
|
|
|
0 |
Symptoms incident or outbreak Pop |
|
|
|
|
|
Finding; Findings; Nominal; Point in time; Public Health; PUBLICHEALTH; Random; Sx; Symptoms incident or outbreak |
2.68 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |